更正:Crinetics Pharmaceuticals第四季度PALSONIFY美国市场净产品收入突破500万美元

美股速递
Jan 05

Crinetics Pharmaceuticals Inc.公布最新财务数据,其核心产品PALSONIFY在美国市场第四季度净销售额超过500万美元。这一业绩表现凸显了该药物在目标治疗领域的商业化进展。

公司此次披露特意澄清了收入统计口径,明确指出相关数字为产品净收入而非季度总收入,同时移除了与IBES预期数据的对比分析。此举旨在更精准地反映产品实际市场表现,为投资者提供清晰的业务进展评估依据。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10